A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study-Reference-Cited by-同舟云学术

A “new” role of amantadines in COVID-19 in patients with Parkinson’s disease: results of own comparative study

Published:2022-12-19 Issue:6 Volume:14 Page:40-48
ISSN:2310-1342
Container-title:Neurology, Neuropsychiatry, Psychosomatics
language:
Short-container-title:RJTAO

Author:

Zalyalova Z. A.¹^ORCID,Munasipova S. E.²^ORCID,Khasanova D. M.³^ORCID,Ilyina G. R.³^ORCID,Khayatova Z. G.⁴^ORCID,Bagdanova N. I.³^ORCID

Affiliation:

1. Kazan State Medical University, Ministry of Health of Russia; Republican Clinical Diagnostic Center for Extrapyramidal Pathology and Botulinum Therapy, Ministry of Health of the Republic of Tatarstan; Hospital for War Veterans; Clinical Hospital “Railway Medicine“

2. Kazan State Medical University, Ministry of Health of Russia; Republican Clinical Diagnostic Center for Extrapyramidal Pathology and Botulinum Therapy, Ministry of Health of the Republic of Tatarstan; Hospital for War Veterans

3. Republican Clinical Diagnostic Center for Extrapyramidal Pathology and Botulinum Therapy, Ministry of Health of the Republic of Tatarstan; Hospital for War Veterans

4. Clinical Hospital “Railway Medicine“

Publisher

IMA Press, LLC

Subject

Psychiatry and Mental health,Neurology (clinical),Clinical Psychology

Reference44 articles.

1. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020 Mar 19;91(1):157-60. doi:10.23750/abm.v91i1.9397

2. RECOVERY Collaborative Group; Horby P, Mafham M, Linsell L, et al. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. 2020 Nov 19;383(21):2030-40. doi:10.1056/NEJMoa2022926. Epub 2020 Oct 8.

3. Sharun K, Dhama K, Patel SK, et al. Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19. Ann Clin Microbiol Antimicrob. 2020 May 30;19(1):23. doi:10.1186/s12941-020-00368-w

4. Ledford H. Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature. 2020 Jun;582(7813):469. doi:10.1038/d41586-020-01824-5

5. Choi SW, Shin JS, Park SJ, et al. Antiviral activity and safety of remdesivir against SARS-CoV-2 infection in human pluripotent stem cell-derived cardiomyocytes. Antiviral Res. 2020 Dec;184:104955. doi:10.1016/j.antiviral.2020.104955. Epub 2020 Oct 19.